标签： Trinidad and Tobago

The importance of diet in cancer prevention, treatment, and recovery is increasingly supported by scientific evidence, according to surgical oncologist Dr. Rajen Rampaul. He highlights that dietary choices not only reduce cancer risk and recurrence but also play a pivotal role in overall health. Regulatory bodies, such as the International Agency for Research on Cancer, have classified certain foods, particularly red meat, as class-one carcinogens, linking them to colorectal and breast cancers. Dr. Rampaul warns against misleading online information about anti-cancer diets and supplements, emphasizing the need for evidence-based medical guidance. He advocates for whole, plant-based diets, such as the Mediterranean or vegetarian patterns, which are associated with longer, healthier lives. Anti-oestrogen foods like soy, beans, spinach, flax seeds, and turmeric are particularly beneficial. Conversely, foods that promote a high-oestrogen environment may increase cancer recurrence risk and should be minimized. Dr. Rampaul also underscores the benefits of fasting, citing a 2020 study that showed intermittent fasting boosts the immune system. He advises avoiding animal proteins and saturated fats, which contribute to inflammation and elevated cancer risk. Smoking and alcohol should also be eliminated to reduce cancer risk. For patients undergoing treatment, Dr. Rampaul emphasizes the importance of pre-habilitation—enhancing nutritional status before treatment begins. He recommends prescribed protein supplements, protein-enriched drinks, and a balanced intake of vitamins and minerals. Hydration is crucial, with a daily intake of at least three liters of water recommended. Post-treatment nutrition should focus on rebuilding strength, maintaining a healthy weight, and reducing recurrence risk through balanced, evidence-based dietary choices. Dr. Rampaul encourages patients to work with dietitians to adapt these principles to local cuisine, ensuring dietary changes are practical and enjoyable. He concludes that adopting a whole-grain, plant-based diet, avoiding processed foods and red meat, and staying hydrated are simple yet powerful steps toward sustained wellness after cancer treatment.

Breast cancer remains one of the most prevalent cancers among women, yet it is often shrouded in myths and misconceptions that can deter individuals from seeking timely care. In an era dominated by digital information, misinformation about breast cancer spreads rapidly through social media, blogs, and casual conversations, often perpetuating unfounded fears and misunderstandings. Dr. Lyronne Olivier, a consultant breast surgeon and associate lecturer at the University of the West Indies, St Augustine, has addressed and debunked several common myths to empower individuals with accurate knowledge and encourage proactive healthcare decisions. One prevalent myth is that breast cancer is solely hereditary. In reality, only 10% of cases are linked to genetic factors, while 90% are sporadic, influenced by environmental and other non-hereditary elements. Another misconception is that breast cancer always presents with pain. However, many cases involve painless lumps, emphasizing the need for clinical evaluation regardless of symptoms. Concerns about mammogram radiation are also unfounded, as the exposure is minimal and significantly outweighed by the benefits of early detection. Additionally, not all breast lumps are cancerous, and lifestyle choices, while beneficial, do not guarantee immunity. Men, though rarely, can also develop breast cancer, and treatment options extend beyond mastectomy, with oncoplastic surgery offering breast preservation. Breast cancer is not a singular disease but comprises various subtypes, each requiring tailored treatment. Mammograms are safe for individuals with breast implants, and products like antiperspirants and underwire bras are not linked to cancer. Finally, eliminating sugar from the diet does not selectively starve cancer cells. Public education and awareness are crucial in combating these myths, fostering early diagnosis, and improving survival rates. Dr. Olivier urges individuals to consult a breast surgeon for any concerns, as early detection remains the cornerstone of effective treatment.

Michelle Clement, a dedicated police officer for 15 years, faced a life-altering moment in October 2022 when she was diagnosed with stage 4, grade 2 invasive lobular carcinoma, a form of breast cancer that had spread to both breasts and her lymph nodes. The news initially plunged her into fear and uncertainty, but Clement chose to lean on her faith and resilience to fight the disease. ‘The first thought that came to my mind was that I was going to die and leave my family behind,’ she recounted. However, she made a conscious decision to choose hope over despair, reminding herself that her faith in God was stronger than any medical diagnosis. Clement’s cancer was hormone receptor-positive, which opened up treatment options that have helped slow the progression of the disease and improve her quality of life. For her, every day is now a victory, and she celebrates small milestones with gratitude. Physically, the treatments have been grueling, leaving her tired, weak, and nauseous. Emotionally, she struggled with the thought of her family’s future without her. Yet, spiritually, she found strength in her faith, holding onto the belief that God’s strength is made perfect in her weakness. Clement’s journey has brought her closer to her family, especially her daughters, Clay-Ann and Chloe, who have been her pillars of support. Clay-Ann, 18, and Chloe, 21, have both been inspired by their mother’s courage and resilience. ‘She is, without a doubt, one of the strongest people I’ve ever known,’ Chloe said. Clement hopes her story will encourage others to prioritize regular screenings and early detection. ‘Cancer is not a death sentence,’ she emphasized. ‘Even at stage 4, you can still live a full, meaningful, and joyful life.’ She urges families facing similar challenges to stay positive, do their research, and surround themselves with uplifting people. Clement dreams of a future where cancer has a cure and looks forward to seeing her children graduate, get married, and start families of their own. Her message to women during Breast Cancer Awareness Month is clear: ‘Cancer is a word, not the end of your story.’

When breast cancer is mentioned, the conversation often centers on women. However, clinical oncologist Dr. Nazreen Bhim emphasizes that breast cancer can affect anyone with breast tissue—including men. Globally, male breast cancer accounts for less than one percent of all cases, but its impact is equally profound. In Trinidad and Tobago (TT), the numbers are similarly small, yet the challenges are significant. Dr. Bhim, who practices at Medical Associates Hospital, highlights that breast cancer is the leading cancer in TT, with male cases forming a minimal fraction of the total. Between 2015 and 2020, the national breast cancer incidence was around 75 per 100,000, with male cases making up less than one percent by international standards. Despite the low prevalence, male breast cancer presents unique challenges, including delayed diagnoses and societal stigma, making awareness crucial. Dr. Bhim, trained at the University of Cape Town and MD Anderson Cancer Center, specializes in advanced radiation therapies and palliative care. She explains that male breast cancer typically affects older men, with a median diagnosis age of 69. Symptoms often include a painless lump near the nipple, nipple retraction, or discharge. Genetic factors, particularly BRCA2 mutations, significantly increase the risk. Unlike women, male breast cancers are more often hormone-receptor positive and less likely to be triple-negative, a more aggressive form. Diagnosis involves mammography, ultrasound, and biopsy, with treatments mirroring those for women, including surgery, systemic therapy, and radiation. Dr. Bhim advocates for increased awareness, genetic testing for high-risk individuals, and rapid-access clinics to reduce diagnostic delays. She also stresses the importance of strengthening data collection to improve outcomes. While TT’s healthcare system has the core capabilities to manage male breast cancer, challenges like wait times and drug access persist. Early detection remains key, as most cases are treatable when caught early.